Multiple pathways contribute to the pathogenesis of Huntington disease

被引：90

作者：

Li, Shihua ^{[1
]}

Li, Xiao-Jiang ^{[1
]}

机构：

[1] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA

来源：

MOLECULAR NEURODEGENERATION | 2006年 / 1卷 / 1期

关键词：

D O I：

10.1186/1750-1326-1-19

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Huntington disease (HD) is caused by expansion of a polyglutamine (polyQ) domain in the protein known as huntingtin (htt), and the disease is characterized by selective neurodegeneration. Expansion of the polyQ domain is not exclusive to HD, but occurs in eight other inherited neurodegenerative disorders that show distinct neuropathology. Yet in spite of the clear genetic defects and associated neurodegeneration seen with all the polyQ diseases, their pathogenesis remains elusive. The present review focuses on HD, outlining the effects of mutant htt in the nucleus and neuronal processes as well as the role of cell-cell interactions in HD pathology. The widespread expression and localization of mutant htt and its interactions with a variety of proteins suggest that mutant htt engages multiple pathogenic pathways. Understanding these pathways will help us to elucidate the pathogenesis of HD and to target therapies effectively.

引用

页数：10

共 148 条

[41] INHIBITION OF SUCCINATE-DEHYDROGENASE BY MALONIC-ACID PRODUCES AN EXCITOTOXIC LESION IN RAT STRIATUM [J].

GREENE, JG ;

PORTER, RHP ;

ELLER, RV ;

GREENAMYRE, JT .

JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) :1151-1154

[42] Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice [J].

Gu, XF ;

Li, CJ ;

Wei, WZ ;

Lo, V ;

Gong, SC ;

Li, SH ;

Iwasato, T ;

Itohara, S ;

Li, XJ ;

Mody, I ;

Heintz, N ;

Yang, XW .

NEURON, 2005, 46 (03) :433-444

[43] Disruption of axonal transport by loss of huntingtin or expression of pathogenic PolyQ proteins in Drosophila [J].

Gunawardena, S ;

Her, LS ;

Brusch, RG ;

Laymon, RA ;

Niesman, IR ;

Gordesky-Gold, B ;

Sintasath, L ;

Bonini, NM ;

Goldstein, LSB .

NEURON, 2003, 40 (01) :25-40

[44]

Gutekunst CA, 1999, J NEUROSCI, V19, P2522

[45] IDENTIFICATION AND LOCALIZATION OF HUNTINGTIN IN BRAIN AND HUMAN LYMPHOBLASTOID CELL-LINES WITH ANTI-FUSION PROTEIN ANTIBODIES [J].

GUTEKUNST, CA ;

LEVEY, AI ;

HEILMAN, CJ ;

WHALEY, WL ;

YI, H ;

NASH, NR ;

REES, HD ;

MADDEN, JJ ;

HERSCH, SM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) :8710-8714

[46] The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human [J].

Gutekunst, CA ;

Li, SH ;

Yi, H ;

Ferrante, RJ ;

Li, XJ ;

Hersch, SM .

JOURNAL OF NEUROSCIENCE, 1998, 18 (19) :7674-7686

[47] The influence of Huntingtin protein size on nuclear localization and cellular toxicity [J].

Hackam, AS ;

Singaraja, R ;

Wellington, CL ;

Metzler, M ;

McCutcheon, K ;

Zhang, TQ ;

Kalchman, M ;

Hayden, MR .

JOURNAL OF CELL BIOLOGY, 1998, 141 (05) :1097-1105

[48] A PRIMATE MODEL OF HUNTINGTONS-DISEASE - BEHAVIORAL AND ANATOMICAL STUDIES OF UNILATERAL EXCITOTOXIC LESIONS OF THE CAUDATE-PUTAMEN IN THE BABOON [J].

HANTRAYE, P ;

RICHE, D ;

MAZIERE, M ;

ISACSON, O .

EXPERIMENTAL NEUROLOGY, 1990, 108 (02) :91-104

[49] The hunt for huntingtin function: interaction partners tell many different stories [J].

Harjes, P ;

Wanker, EE .

TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (08) :425-433

[50] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease [J].

Hockly, E ;

Richon, VM ;

Woodman, B ;

Smith, DL ;

Zhou, XB ;

Rosa, E ;

Sathasivam, K ;

Ghazi-Noori, S ;

Mahal, A ;

Lowden, PAS ;

Steffan, JS ;

Marsh, JL ;

Thompson, LM ;

Lewis, CM ;

Marks, PA ;

Bates, GP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2041-2046

← 1 2 3 4 5 6 7 8 9 10 →